Eli Lilly & Company (NYSE:LLY) – Lilly and Immunocore Enter Immunotherapy Agreement to Co-Discover and Co-Develop Novel Cancer Therapies

[PR Newswire] – OXFORD, England and INDIANAPOLIS, July 16, 2014 /PRNewswire/ — Eli Lilly and Company (LLY) and Immunocore Limited today announced they have entered into a co-discovery and co-development collaboration to research . . . → Read More: Eli Lilly & Company (NYSE:LLY) – Lilly and Immunocore Enter Immunotherapy Agreement to Co-Discover and Co-Develop Novel Cancer Therapies Similar Articles: Market Update (NYSE:LLY): Lilly Declares Second-Quarter 2014 Dividend Stock Update: Eli Lilly & Company (NYSE:LLY) – Lilly Reports First-Quarter 2014 Results Stock Update (NYSE:LLY): U.S. FDA approves Eli Lilly drug for stomach cancer